120 HOLBORN, LONDON, EC1N 2SQ, ENGLAND
- Tel:
- Work 020 7830 0000
- Fax:
- Fax 020 7830 0001
- Web:
- www.mathys-squire.com
- Email:
Martin Maclean
- Tel:
- Work +44 20 7830 0000
- Email:
Work Department
Intellectual property.
Position
Martin specialises in technologies such as the re-targeting of bacterial toxins, vaccines, expression systems, microbial detection assays, cytokine-based therapeutics, and agrochemicals, and represents clients ranging from UK government and blue chip biotech companies through to spin-outs and start-ups. Martin’s principal practice areas include drafting and global prosecution, defence and opposition, freedom-to-operate, and strategic advice. In this regard, Martin has extensive experience in the conduct of Hearings before the European Patent Office, having conducted in excess of 70 Hearings -examples include “HIV peptides;’ (Adaltis, Abbott Lab, United Biomedical, lnstitut Pasteur, Bio-Rad Pasteur), “Factor XIII” (Novo Nordisk, Baxter, Aventis Behring), “TACI” (ZymoGenetics, Corixa: HGS), “Omega- 3” (Martek Biosciences. Nagase Biochem, Aventis R&T, OmegaTech, Monsanto), “Stomachaction molluscicides” (Young, W.Neudorff GmbH), “Pesticidal compositions” (W.Neudorff GmbH, Bayer Cropscience AG): “Aqueous pesticide formulations” (Monsanto, Nufarm Australia Limited, Rhodia Operations), “RNase P detection of pathogenic organisms” (Herrmann; MacLean), “Detection of microbial residues” (DSM IP Assets. Charm Sciences), ‘’One-step detection of antimicrobial residues” (DSM IP Assets, Charm Sciences). “Clonal virus therapeutics” (Wellstat Biologics, Bayer Schering Pharma AG), “Propagation and directed differentiation of CNS stem cells” (Neuralstem Biopharma. Stem Cells Inc.). Martin is a member of the Life Sciences Committee for the Chartered Institute of Patent Attorneys, and acts as a tutor for the UK and European Qualifying Examinations. He also serves as a lecturer and clinician for the Chartered Institute of Patent Attorneys. Chambers 2011 ranks Martin as a ‘Key Individual’ for biochemistry and biotechnology patents and praises him for being “diligent and proactive. and provides excellent strategic advice”.
Career
Qualified patent attorney 1999; joined Mathys & Squire 1999; partner 2004. Martin is a Chartered Patent Attorney and European Patent Attorney.
Member
Chartered Institute of Patent Attorneys.
Education
Warwick University) (BA First Class Microbial Technology; PhD for research conducted into the biochemical aspects of acidophilic bacteria); London University (MA Intellectual Property).
